Fatih Kocabas



Dr. Kocabas received his B.S. in Molecular Biology and Genetics from Middle East Technical University and his Ph.D. in Genetics and Development from University of Texas Southwestern (UTSW) Medical Center at Dallas. He developed a metabolic approach to isolate stem cells from bone marrow and heart, which lead him to discover unique metabolic profile of mouse hematopoietic stem cells (HSCs) (published in Cell Stem Cells), human HSCs (in submission), glycolytic cardiac progenitors (GCPs) (published in JCTR) and their respective cardiac hypoxic niche. In addition, his studies using novel mouse heart regeneration model lead to discovery of Meis1 that regulates the heart’s ability to regenerate after injuries (published in Nature). He received several awards such as fellowship at California Institute of Technology (Caltech) (2005), GSO Travel Award from UTSW (2012), New Investigator Travel Award from American Heart Association (2012), Experienced Researcher Scholarship (CO-Funded Brain Circulation Scheme -The Marie Curie Action 7th. Framework Programme (FP7) & TÜBİTAK, 2015) and MC-IF Eşik Üstü Award (Tubitak, 2015). In addition, he got special training in “Basic hESCs and hiPSCs Biology” at Stanford University. He is now leading regenerative biology research group at Yeditepe University, Istanbul. His professional activities include editorship for a special issue on “Regenerative and Restorative Biology” to be published in Turkish Journal of Biology, editorial board member of Turkish Journal of Biology, Journal of New Science Biotechnology, Archives of Stem Cell Research, International Journal of Biological Sciences and Applications, Health Sciences Research, International Journal of Biophysics and Biochemistry and International Journal of Stem cell Research & Therapy. His research interests include elucidating the molecular mechanisms of regenerative ability of neonatal mice myocardium, small molecule induced reactivation of cardiomyocyte cell cycle, identification of metabolically distinct tissue and cancer specific stem cells using metabolic profiling, and in vivo and ex vivo small molecule induced stem cell expansion.

Record last modified Aug 29, 2018 1:28:01 PM